In cohort 2, 100 FFPE tumour specimens from CRC patients previously analyzed by ME-PCR and DS were retrospectively tested by the SensiScreen® FFPE BRAF qPCR simplex Assay. This evidence concerns the gene BRAF and neoplasm.